InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Dicicco Wendy F, 董事. Director active across 4 companies, notably Renovacor, Inc.. Aggregated, 10 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €18k. History available since 24 January 2022. The latest transaction was disclosed on 20 August 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
DICICCO WENDY F is Interim Chief Financial Officer and Director. She is linked to SWK Holdings Corp, EyePoint Pharmaceuticals, Inc., Renovacor, Inc. and Akari Therapeutics Plc. The record shows 10 filings in total, and within the sampled recent filings the period runs from 2022-01-26 to 2024-08-21, with buys of EUR 17970 and no sells; the modal transaction nature is Attribution.